Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed an expansion of its partnership with Maastricht University to develop genetic and epigenetic cancer diagnostics.

Under the terms of the multiyear deal, MDxHealth will collaborate with Maastricht's Faculty of Health, Medicine, and Life Sciences institute and its School for Oncology and Developmental Biology to develop genetic and epigenetic assays for diagnosing, staging, and treating cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.